International Journal of Endocrinology and Metabolism

Published by: Kowsar

Gonadotropin-Releasing Hormone Agonist Therapy and Obesity in Girls

Kobra Shiasi Arani 1 , * and Fatemeh Heidari 2
Authors Information
1 Department of Pediatric Endocrinology, Research Center for Biochemistry and Nutrition in Metabolic Disorders, Kashan University of Medical Sciences, Kashan, IR Iran
2 Nekoei-Hedayati Therapeutic Educational Center, Qom University of Medical Sciences, Qom, IR Iran
Article information
  • International Journal of Endocrinology and Metabolism: July 01, 2015, 13 (3); e23085
  • Published Online: July 1, 2015
  • Article Type: Research Article
  • Received: September 2, 2014
  • Revised: March 3, 2015
  • Accepted: May 26, 2015
  • DOI: 10.5812/ijem.23085v2

To Cite: Shiasi Arani K, Heidari F. Gonadotropin-Releasing Hormone Agonist Therapy and Obesity in Girls, Int J Endocrinol Metab. 2015 ; 13(3):e23085. doi: 10.5812/ijem.23085v2.

Copyright © 2015, Research Institute For Endocrine Sciences and Iran Endocrine Society. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Rosenfield RL, Lipton RB, Drum ML. Thelarche, pubarche, and menarche attainment in children with normal and elevated body mass index. Pediatrics. 2009; 123(1): 84-8[DOI][PubMed]
  • 2. Mogensen SS, Aksglaede L, Mouritsen A, Sorensen K, Main KM, Gideon P, et al. Diagnostic work-up of 449 consecutive girls who were referred to be evaluated for precocious puberty. J Clin Endocrinol Metab. 2011; 96(5): 1393-401[DOI][PubMed]
  • 3. Kim HK, Kee SJ, Seo JY, Yang EM, Chae HJ, Kim CJ. Gonadotropin-releasing hormone stimulation test for precocious puberty. Korean J Lab Med. 2011; 31(4): 244-9[DOI][PubMed]
  • 4. Fuqua JS. Treatment and outcomes of precocious puberty: an update. J Clin Endocrinol Metab. 2013; 98(6): 2198-207[DOI][PubMed]
  • 5. Ságodi L, Sólyom E, Lomb ay B, Almási A, Vámosi I. The effect of gonadotropin releasing hormone analogue therapy in girls with idiopathic central precocious puberty. Orvosi Hetilap. 2012; 153(11): 418-24[DOI]
  • 6. Traggiai C, Perucchin PP, Zerbini K, Gastaldi R, De Biasio P, Lorini R. Outcome after depot gonadotrophin-releasing hormone agonist treatment for central precocious puberty: effects on body mass index and final height. Eur J Endocrinol. 2005; 153(3): 463
  • 7. Karamizadeh Z, Tabebordbar M, Saki F, Karamifar H, Amirhakimi G. The side effects of gonadotropin releasing hormone analog (diphereline) in treatment of idiopathic central precocious puberty. Acta Med Iran. 2013; 51(1): 41-6[PubMed]
  • 8. Lee SJ, Yang EM, Seo JY, Kim CJ. Effects of gonadotropin-releasing hormone agonist therapy on body mass index and height in girls with central precocious puberty. Chonnam Med J. 2012; 48(1): 27-31[DOI][PubMed]
  • 9. Tascilar ME, Bilir P, Akinci A, Kose K, Akcora D, Inceoglu D, et al. The effect of gonadotropin-releasing hormone analog treatment (leuprolide) on body fat distribution in idiopathic central precocious puberty. Turk J Pediatr. 2011; 53(1): 27-33[PubMed]
  • 10. Palmert MR, Mansfield MJ, Crowley WJ, Crigler JJ, Crawford JD, Boepple PA. Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty. J Clin Endocrinol Metab. 1999; 84(12): 4480-8[DOI][PubMed]
  • 11. Glab E, Barg E, Wikiera B, Grabowski M, Noczynska A. Influence of GnRH analog therapy on body mass in central precocious puberty. Pediatr Endocrinol Diabetes Metab. 2009; 15(1): 7-11[PubMed]
  • 12. Yuan JN, Liang L, Cai XD, Li Z, Bai M, Gu CP. [Impact of gonadotropin-releasing hormone analogs on body mass index in girls with idiopathic central precocious puberty: a long-term follow-up study]. Zhongguo Dang Dai Er Ke Za Zhi. 2011; 13(11): 896-9[PubMed]
  • 13. Ko JH, Lee HS, Lim JS, Kim SM, Hwang JS. Changes in bone mineral density and body composition in children with central precocious puberty and early puberty before and after one year of treatment with GnRH agonist. Horm Res Paediatr. 2011; 75(3): 174-9[DOI][PubMed]
  • 14. Park HK, Lee HS, Ko JH, Hwang IT, Lim JS, Hwang JS. The effect of gonadotrophin-releasing hormone agonist treatment over 3 years on bone mineral density and body composition in girls with central precocious puberty. Clin Endocrinol (Oxf). 2012; 77(5): 743-8[DOI][PubMed]
  • 15. Poomthavorn P, Suphasit R, Mahachoklertwattana P. Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment. Gynecol Endocrinol. 2011; 27(8): 524-8
  • 16. Arrigo T, De Luca F, Antoniazzi F, Galluzzi F, Segni M, Rosano M, et al. Reduction of baseline body mass index under gonadotropin-suppressive therapy in girls with idiopathic precocious puberty. European journal of endocrinology. 2004; 150(4): 533-7
  • 17. centers for disease control and prevention . Using the BMI-for-Age Growth Charts. 2009;
  • 18. Paxton ML, Lamont AC, Stillwell AP. The reliability of the Greulich-Pyle method in bone age determination among Australian children. J Med Imaging Radiat Oncol. 2013; 57(1): 21-4[DOI][PubMed]
  • 19. Bar A, Linder B, Sobel EH, Saenger P, DiMartino-Nardi J. Bayley-Pinneau method of height prediction in girls with central precocious puberty: correlation with adult height. J Pediatr. 1995; 126(6): 955-8[PubMed]
  • 20. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969; 44(235): 291-303[PubMed]
  • 21. Wang ZF, Li GJ. [Value evaluation of follicle stimulating hormone and luteinizing hormone in the diagnosis of precocious puberty in girls by ROC curve analysis]. Zhongguo Dang Dai Er Ke Za Zhi. 2012; 14(6): 441-4[PubMed]
  • 22. [Central precocious puberty: epidemiology, etiology, diagnosis and treatment]. Anales de pediatria (Barcelona, Spain: 2003). : 336. e1-336. e13
  • 23. Liang JT. [Value of basal serum gonadotropin levels in the diagnosis of precocious puberty in girls]. Zhongguo Dang Dai Er Ke Za Zhi. 2012; 14(12): 942-5[PubMed]
  • 24. Feuillan PP, Jones JV, Barnes K, Klein KO, Cutler GJ. Follow-up of children and young adults after GnRH-agonist therapy or central precocious puberty. J Endocrinol Invest. 2001; 24(9): 734-6[PubMed]
  • 25. Oostdijk W, Rikken B, Schreuder S, Otten B, Odink R, Rouwe C, et al. Final height in central precocious puberty after long term treatment with a slow release GnRH agonist. Arch Dis Child. 1996; 75(4): 292-7[PubMed]
  • 26. Gillis D, Karavani G, Hirsch HJ, Strich D. Time to menarche and final height after histrelin implant treatment for central precocious puberty. J Pediatr. 2013; 163(2): 532-6[DOI][PubMed]
  • 27. Boot AM, Keizer-Schrama SMPFM, Pols HAP, Krenning EP, Drop SLS. Bone Mineral Density and Body Composition before and during Treatment with Gonadotropin-Releasing Hormone Agonist in Children with Central Precocious and Early Puberty 1. J Clin Endocrinol Metabol. 1998; 83(2): 370-3
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments